Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jishanth Mattumpuram"'
Autor:
Vikash Jaiswal, Song Peng Ang, Novonil Deb, Muhammad Hanif, Nitya Batra, Sai Gautham Kanagala, Nikhil Vojjala, Kripa Rajak, Poulami Roy, Medha Sharath, Madeeha Subhan Waleed, Zarghoona Wajid, Jishanth Mattumpuram
Publikováno v:
Medicina, Vol 60, Iss 4, p 580 (2024)
Background: Chemotherapy-induced cardiac dysfunction (CIC) is a significant and concerning complication observed among cancer patients. Despite the demonstrated cardioprotective benefits of statins in various cardiovascular diseases, their effectiven
Externí odkaz:
https://doaj.org/article/870c077530c44024bf2e1a6636ba1787
Autor:
Andrea Torres, Yasmeen Golzar, Juan Del Cid Fratti, Hashim Mann, Tauseef Akhtar, Setri Fugar, Chineme Nwaichi, Alok Uprety, Jishanth Mattumpuram
Publikováno v:
International Journal of Cardiology. 320:78-82
Background Rivaroxaban is a direct oral anticoagulant (DOAC) approved for the treatment of non-valvular atrial fibrillation (NVAF). Data related to the risk factors associated with rivaroxaban-induced bleeding in patients with NVAF remain scarce in t
Autor:
Min Zhuo, Sagar Ranka, Wilbert S. Aronow, Rohit Agrawal, Jishanth Mattumpuram, Muhammad Tahir Khan, Tauseef Akhtar, Jayakumar Sreenivasan, Qiyu Wang, Neha Yadav
Publikováno v:
Archives of Medical Science - Civilization Diseases. 5:29-34
Autor:
Muhammad Asghar, Nathan A Neilson, Minchul Kim, Jishanth Mattumpuram, Michael Tye, Sudhir Mungee, Mansoor Ahmad
Publikováno v:
Cureus
Background and objective In patients undergoing coronary angiogram, the degree of cardiac enzyme elevation at presentation has been thought of as a strong and independent predictor of in-hospital mortality and readmission. Recent studies, however, ha
Publikováno v:
Journal of the American College of Cardiology. 75:2965
Stent thrombosis(ST) is a devastating complication of PCI. Dual antiplatelet therapy (DAPT) interruption is the strongest predictor of ST, and the highest risk is in the first 6 weeks. Therefore, surgical treatments within 6 weeks of PCI is a challen
Autor:
Aakash Putta, Sagar Ranka, Juan Del Cid Fratti, Alok Uprety, Jishanth Mattumpuram, Hashim Mann, Setri Fugar, Tauseef Akhtar, Yasmeen Golzar
Publikováno v:
Journal of the American College of Cardiology. 73:471
Publikováno v:
Journal of the American College of Cardiology. 73:2638
Esophagopericardial fistula (EPF) is a rare condition with extremely high in-hospital mortality. Most presentations are in the setting of iatrogenic manipulation during endoscopies, atrial fibrillation catheter ablation, foreign body perforations or
Autor:
Koosha Paydary, Jiaxiang Liu, Jayasree Krishnan, Barbra Yim, Alok Uprety, Jishanth Mattumpuram, Aakash Putta, Ankit Mangla, Tauseef Akhtar, Muhammad Umair Mushtaq, Yanting Wang, Thomas E. Lad, Hashim Mann
Publikováno v:
Blood. 132:5064-5064
Introduction: Rivaroxaban is a target specific oral anticoagulant approved for treatment of deep venous thromboembolism (DVT), pulmonary embolism (PE) and risk reduction in patients with DVT/PE requiring continued anticoagulation. The XALIA study sho